E-Mail:
Password:
Home | Stock Market Blogs | Financial Tools | Sign Up Free
 

gear headHow cool is this? Shampoo for men in a quart of oil bottle!

Click the banner to get some now and tell the little lady to throw that other stuff in the trash!
Biovest International, Inc.  
Biovest International, Inc.
BVTILast: $1.44 ($+0.09)Volume: 40,726Last Trade: 8/5/2010 5:20:03 PM
Today

Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year
 Options
Quote |  Alerts | | Free Newsletter
 
 Detailed Quote
OTC PK:BVTI $1.44 ($+0.09 +6.6666%)
Industry: Health Sector: Pharmaceuticals
Open: 1.40 Previous Close: 1.35
Day's High: 1.45 Day's Low: 1.31
52-Week High: 1.04 52-Week Low: 0.32
 
Volume: 40,726 Outstanding: 95,729,729
Market Cap: $59 M
Biovest International, Inc. Profile
Biovest International is a biotechnology company focused on the development of BiovaxID , a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma, or follicular NHL. It has historically developed, manufactured and marketed patented cell culture systems and equipment to pharmaceutical, diagnostic and biotechnology companies, as well as research institutions worldwide, and has provided contract cell production services to those institutions. While continuing this business, management has chosen to re-orient Co.'s focus, assets and operations to increase contract cell production and biologic drug development and ownership.
 Biovest International, Inc. News & Press Releases

Accentia Biopharmaceutical's Revimmune Receives the Frost ...
PR-Inside.com (Pressemitteilung): Accentia Biopharmaceutical's Revimmune Receives the Frost ... , Austria - Mar 17, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BV

Accentia Biopharmaceutical's SinuNase Featured as ``Future ...
PR-Inside.com (Pressemitteilung): Accentia Biopharmaceutical's SinuNase Featured as ``Future ... , Austria - Mar 15, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:B

Accentia Biopharmaceutical’s Revimmune Receives the Frost ...
Business Wire (press release): Accentia Biopharmaceutical’s Revimmune Receives the Frost ... , CA - Mar 13, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BVTI ) and

Businessnewsnow.us: Yesterdays Stock News Recap: ABPI, HMSY, CRMH ...
Insurance News Net (press release): Businessnewsnow.us: Yesterdays Stock News Recap: ABPI, HMSY, CRMH ... , PA - Mar 12, 2008 Additionally, through an investment strategy, the Company has acquired the majority ownership interest in Biovest International, Inc. ( OTCBB:BVT


Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign UpCopyright © 2014
SmallCapWatch, LLC.
Never invest based soley on information from this website or our e-mail and IM alerts